Moss, 9 May 2022
The nomination committee of Gentian Diagnostics ASA has submitted its recommendation regarding the election of members to the Company's board of directors and the nomination committee, including proposed remuneration to members of the board and nomination committee.
The recommendation is enclosed and available on www.gentian.com
This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.
IR contact:
Njaal Kind, CFO and COO
njaal.kind@gentian.no
+47 919 06 525 (mobile)